Harel Insurance Investments & Financial Services Ltd. Protalix Bio Therapeutics, Inc. Transaction History

Harel Insurance Investments & Financial Services Ltd.

$11.1 Billion
Q3 2025

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2025 Aug 05, 2025	BUY	$1.35 - $3.07 $35,100 - $79,820	26,000 New	26,000 $40,000

Others Institutions Holding PLX

# of Institutions

Shares Held

10.6M

Call Options Held

23.6K

Put Options Held

95.4K

Opaleye Management Inc. Boston, MA

2.58M
Shares

$4.8 Million
0.96% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

1.32M
Shares

$2.45 Million
0.0% of portfolio
Northern Trust Corp Chicago, IL

902K
Shares

$1.68 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

820K
Shares

$1.52 Million
0.0% of portfolio
Stratos Wealth Partners, Ltd.

500K
Shares

$930,000
0.01% of portfolio

View Full List

About Protalix BioTherapeutics, Inc.

Ticker PLX
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,753,400
Market Cap $92.5M
Description
Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...

More about PLX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harel Insurance Investments & Financial Services Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Harel Insurance Investments & Financial Services Ltd. with notifications on news.

Account